（编辑 王雪儿） 证券日报网讯 广康生化8月18日在互动平台回答投资者提问时表示，公司应收账款增长主要因为收入增 长所致，公司经营活动现金流持续向好。2025年一季度，经营活动现金流净额422.42万元，同比增长 382.43%；2024年全年净额1434.48万元，同比增长14.79%。公司根据客户行业地位、合作情况并综合考 虑市场环境等因素给予不同信用政策。目前，公司海外客户应收账款均在合同约定的信用期内，未来公 司将持续加强应收账款管理，提升资金周转效率。 ...

Group 1 - The stock price of Guangkang Biochemical is reported at 42.42 yuan, down by 0.15 yuan from the previous trading day, with an intraday high of 42.92 yuan and a low of 42.26 yuan, resulting in an overall fluctuation of 1.55% [1] - The trading volume for the day was 16,386 hands, with a total transaction amount of 0.70 billion yuan [1] - Guangkang Biochemical's main business includes the research, production, and sales of pesticide raw materials, formulations, and intermediates, covering three major categories: insecticides, fungicides, and herbicides, primarily used in agricultural production [1] Group 2 - As of the current date, Guangkang Biochemical has a total market capitalization of 31.39 billion yuan and a circulating market value of 11.67 billion yuan [1]

Group 1 - The stock price of Guangkang Biochemical closed at 42.52 yuan on August 5, 2025, down 0.47% from the previous trading day [1] - The stock exhibited volatility, with a minimum price of 41.89 yuan and a maximum of 43.31 yuan, resulting in a fluctuation of 3.32% [1] - A notable rebound occurred around 13:02, where the stock price increased by over 2% within five minutes, reaching 43.08 yuan [1] Group 2 - Guangkang Biochemical's main business includes the research, production, and sales of pesticide raw materials and formulations, covering categories such as insecticides, fungicides, and herbicides [1] - The company's products are primarily used in agricultural production, addressing the needs for crop protection [1] Group 3 - On August 5, the net outflow of main funds was 4.9359 million yuan, with a cumulative net outflow of 41.048 million yuan over the past five trading days [1] - The trading volume for the day was 26,073 hands, with a transaction amount of 111 million yuan and a turnover rate of 9.48% [1]

证券之星消息，8月5日农化制品板块较上一交易日上涨0.34%，丰山集团领涨。当日上证指数报收于 3617.6，上涨0.96%。深证成指报收于11106.96，上涨0.59%。农化制品板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 603810 | 丰山集团 | 17.27 | 3.85% | 3.14万 | 5362.57万 | | 002734 | 利民股份 | 21.88 | 2.87% | 59.84万 | 12.96ZZI | | 000422 | 湖北宣化 | 13.54 | 2.19% | 27.13万 | 3.63亿 | | 000902 | 新洋丰 | 14.40 | 1.91% | 10.80万 | 1.55亿 | | 300387 | 富邦科技 | 9.54 | 1.81% | 9.53万 | 9061.10万 | | 002545 | 东方铁塔 | 9.86 | 1.75% | 11.65万 | 1.15亿 | | 002470 | 金正大 | 1.7 ...

证券日报网讯广康生化（300804）7月31日在互动平台回答投资者提问时表示，公司目前未直接面向终 端市场销售卫生用药产品。该类产品主要供应给跨国企业，由其负责后续的对外销售，相关收入在公司 整体营收中占比较小。经核实，公司目前拥有登记证号WP开头的产品6个。 ...

Group 1 - The company, Guangkang Biochemical (300804.SZ), does not sell sanitary pharmaceuticals directly to the end market, instead supplying these products to multinational companies responsible for external sales [1] - The revenue from sanitary pharmaceuticals constitutes a small proportion of the company's overall revenue [1] - The company currently holds six product registration numbers starting with WP [1] Group 2 - An investor inquired about the company's registration and business situation in the sanitary pharmaceutical sector, specifically regarding three registered products for mosquito control [3] - The registered products include cis-chlordimeform suspension agent, wettable powder, and high-efficiency chlordimeform suspension agent [3] - The company's previous statements indicated a lack of relevant registration qualifications and plans in the sanitary pharmaceutical field, prompting the need for clarification [3]

广康生化（300804.SZ）7月29日在投资者互动平台表示，您好！公司目前无卫生杀虫领域的产品登记计 划。 每经AI快讯，有投资者在投资者互动平台提问：请问公司针对卫生杀虫领域的资质登记是否已有明确 推进计划？ （文章来源：每日经济新闻） ...

Core Viewpoint - Guangkang Biochemical (300804) focuses on the research, production, and sales of pesticide raw materials, intermediates, and formulations, with some products showing effectiveness in mosquito control [1] Company Overview - The company has not obtained the necessary registration qualifications for health pesticides, which are required for products used in public health pest control [1] - The company emphasizes the need to comply with relevant laws and regulations when using its products in the health pest control sector [1]

格隆汇7月29日丨广康生化(300804.SZ)在互动平台表示，我司的主营业务是农药原药、中间体、制剂的 研发、生产和销售。我司生产的部分农药杀虫剂对灭蚊有一定的防治效果，但我司产品若要用于卫生杀 虫领域，则需严格遵守相关法律法规，取得相关登记审批和资质认证。目前，公司未取得卫生用农药相 关登记资质。 ...

广州市天河区珠江新城珠江西路 21 号 粤海金融中心 28 层 邮编：510627 电话：(86-20) 2805-9088 传真：(86-20) 2805-9099 北京市君合（广州）律师事务所 关于广东广康生化科技股份有限公司 2025 年第一次临时股东大会的法律意见 致：广东广康生化科技股份有限公司 北京市君合（广州）律师事务所（以下简称"本所"）接受广东广康生化科技股份 有限公司（以下简称"公司"）的委托，指派本所经办律师出席了公司于 2025 年 7 月 28 日在广东省广州市天河区高普路 97 号 A-B 座 6 楼（601-603 房）会议室召开的 2025 年第一次临时股东大会（以下简称"本次股东大会"）的现场会议。现根据《中华人民 共和国公司法》（以下简称"《公司法》"）、《中华人民共和国证券法》《上市公司股东 会规则》《深圳证券交易所创业板股票上市规则》等中国（为本法律意见之目的，"中国" 特指中华人民共和国大陆地区）现行法律、法规和规范性文件（以下简称"法律、法规"） 以及《广东广康生化科技股份有限公司章程》（以下简称"公司章程"）、《广东广康生化 科技股份有限公司股东大会议事规则》（以 ...